ASCP Corner: Choice of Antipsychotic in HIV-Infected Patients
J Clin Psychiatry 2007;68(3):479-480
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Human immunodeficiency virus (HIV) infection is associated with a wide range of mental illnesses.1–9 Some are due to HIV infection itself; others are higher in prevalence than among the general population due to a more frequent comorbidity associated with HIV risk factors. Psychosis is one that has been less frequently studied.